CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 27, 2022
Cash flows from operating activities:
Net cash provided by operating activities	$ 46,677	$ 139,321
Cash flows from investing activities:
Capital expenditures	(45,114)	(27,999)
Origination of finance receivables	(917,145)	(1,058,461)
Collections on finance receivables	890,852	965,190
Other investing activities	821	135
Net cash used by investing activities	(70,586)	(121,135)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	693,276	495,785
Repayments of medium-term notes	(350,000)	(550,000)
Proceeds from securitization debt	547,706	0
Repayments of securitization debt	(310,640)	(271,499)
Borrowings of asset-backed commercial paper	0	62,455
Repayments of asset-backed commercial paper	(62,634)	(56,634)
Net (decrease) increase in unsecured commercial paper	(270,119)	64,521
Net increase in deposits	51,822	57,660
Dividends paid	(24,123)	(24,056)
Repurchase of common stock	(96,767)	(261,737)
Other financing activities	69	0
Net cash provided (used) by financing activities	178,590	(483,505)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	3,820	(1,743)
Net increase (decrease) in cash, cash equivalents and restricted cash	158,501	(467,062)
Cash, cash equivalents and restricted cash, beginning of period	1,579,177	2,025,219
Net increase (decrease) in cash, cash equivalents and restricted cash	158,501	(467,062)
Cash, cash equivalents and restricted cash, end of period	1,737,678	1,558,157
Reconciliation of cash, cash equivalents and restricted cash on the Consolidated balance sheets to the Consolidated statements of cash flows:
Cash and cash equivalents	1,561,200	1,393,731
Restricted cash	164,965	142,812
Restricted cash included in Other long-term assets	11,513	21,614
Cash, cash equivalents and restricted cash per the Consolidated statements of cash flows	$ 1,737,678	$ 1,558,157